- Home
- CASS vs MLTX Comparison
CASS vs MLTX Comparison
Compare CASS & MLTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CASS
- MLTX
- Stock Information
- Founded
- CASS 1906
- MLTX 2021
- Country
- CASS United States
- MLTX Switzerland
- Employees
- CASS N/A
- MLTX N/A
- Industry
- CASS Business Services
- MLTX Biotechnology: Pharmaceutical Preparations
- Sector
- CASS Consumer Discretionary
- MLTX Health Care
- Exchange
- CASS Nasdaq
- MLTX Nasdaq
- Market Cap
- CASS 533.8M
- MLTX 535.3M
- IPO Year
- CASS 1996
- MLTX N/A
- Fundamental
- Price
- CASS $38.87
- MLTX $9.40
- Analyst Decision
- CASS Buy
- MLTX Buy
- Analyst Count
- CASS 2
- MLTX 9
- Target Price
- CASS $48.00
- MLTX $37.63
- AVG Volume (30 Days)
- CASS 51.8K
- MLTX 9.7M
- Earning Date
- CASS 10-17-2025
- MLTX 11-06-2025
- Dividend Yield
- CASS 3.19%
- MLTX N/A
- EPS Growth
- CASS N/A
- MLTX N/A
- EPS
- CASS 1.86
- MLTX N/A
- Revenue
- CASS $219,841,000.00
- MLTX N/A
- Revenue This Year
- CASS N/A
- MLTX N/A
- Revenue Next Year
- CASS $7.81
- MLTX N/A
- P/E Ratio
- CASS $20.91
- MLTX N/A
- Revenue Growth
- CASS 5.05
- MLTX N/A
- 52 Week Low
- CASS $38.01
- MLTX $5.95
- 52 Week High
- CASS $47.14
- MLTX $62.75
- Technical
- Relative Strength Index (RSI)
- CASS 29.48
- MLTX 23.29
- Support Level
- CASS $38.51
- MLTX $6.56
- Resistance Level
- CASS $39.83
- MLTX $7.48
- Average True Range (ATR)
- CASS 0.84
- MLTX 2.22
- MACD
- CASS -0.21
- MLTX -4.37
- Stochastic Oscillator
- CASS 9.06
- MLTX 6.07
About CASS Cass Information Systems Inc
Cass Information Systems Inc is a provider of payment and information processing services to large manufacturing, distribution and retail enterprises across the United States. The company provides transportation invoice rating, payment processing, auditing, accounting, and transportation information. It is also a processor and payer of energy invoices, including electricity, gas, waste, and other facility-related expenses. It operates in two segments: Information Services and Banking Services. The firm generates maximum revenue from the Information Services segment, which provides transportation, energy, telecommunication, and environmental invoice processing and payment services to large corporations.
About MLTX MoonLake Immunotherapeutics
MoonLake Immunotherapeutics is a clinical-stage biotechnology company advancing therapies to address unmet needs in inflammatory skin and joint diseases. The company is focused on the development of SLK, a novel tri-specific IL-17A and IL-17F inhibiting Nanobody that has the potential, based on response levels seen in clinical trials, to drive disease modification in dermatology and rheumatology patients.